Healthcare perspectives from The Economist Intelligence Unit

Color

#DB444B

Hero Carousel

Spotlight

Bringing healthcare to hard-hit areas in Bangladesh

YouTube

https://www.youtube.com/channel/UCQDMOSbJtqrtNzif5rS22OQ

Slideshare

http://www.slideshare.net/economistintelligenceunit

Pinterest

https://www.pinterest.com/theeiu/

The future of healthcare in Africa

Healthcare demands in Africa are changing. Ensuring access to clean water and sanitation, battling ongoing communicable diseases and stemming the tide of preventable deaths still dominate the healthcare agenda in many countries. However, the incidence of chronic disease is rising fast, creating a new matrix of challenges for Africa’s healthcare workers, policy makers and donors.

The value challenge

Report Summary

The value challenge is the second in a series of four reports by the Economist Intelligence Unit, following the first report, The innovation imperative in biopharma. These reports are part of the Reinventing biopharma: Strategies for an evolving marketplace programme, sponsored by Quintiles. The Economist Intelligence Unit conducted the survey and analysis and wrote the report. The findings and views expressed in this report do not necessarily reflect the views of the sponsor.

Finding alignment

After years of painfully diminishing return on investment (ROI) from discovery and development (D&D) programmes, pharmaceutical and biotechnology companies are taking a calculated risk at the heart of their businesses with the production of their most valuable asset—intellectual property. Within the last decade, outsourcing to contract research organisations (CROs)—companies that offer the industry a wide range of research services—has grown to such an extent that it now encompasses over 40% of the entire sector’s D&D.

A new vision for old age

The good news is that Europe is ageing. In a little over half a century, the average life expectancy has gone from 66 to 75, and by 2050 is predicted to hit 82. This is not simply because people are not dying young, but because they are living to older ages than ever: the over 85s are the fastest growing demographic group on the continent. But for many, the good news is also bad news, because in many respects—notably pensions, social care and health provision—European societies are not prepared for this demographic shift.

Connect to care

Report Summary

Connect to care: The future of healthcare IT in South Korea investigates whether the country is set to use healthcare IT—particularly systems that enable data sharing across providers, and remote monitoring and diagnosis—to combat problems in its healthcare system exacerbated by an ageing population and inefficiencies in delivery. 

The findings and views expressed here are those of the EIU alone and do not necessarily reflect the views of the sponsor.

Getting it all together

Breast cancer is the most common cancer in Australian women. The good news is that more Australian women are surviving it than ever before, and Australia ranks highly among its developed-economy peers in terms of patients’ access to cutting-edge treatments, mortality rates and chances of long-term survival. Nevertheless, it also shares with other rich countries a rising incidence rate as its population ages. And although advanced in several senses, breast cancer control in Australia faces some unique challenges.

Future-proofing Western Europe's healthcare

The report was sponsored by Eucomed, the European medical technology association. It is based on in-depth interviews with more than 25 medical professionals and experts in five European countries.

Beyond logistics

Beyond logistics: Meeting customer needs for in-home service is an Economist Intelligence Unit report sponsored by TOA Technologies. The report explores how in-home service providers can respond to increasing demands from their customers and build a strong brand that distinguishes their offerings from those of their competitors in an increasingly crowded marketplace.

The innovation imperative in biopharma

It’s not easy being a life sciences firm today. Companies in the sector have seen rising research and development (R&D) costs, in exchange for flat, or even diminishing, innovation returns. Many are staring over the edge of a patent cliff, the loss of intellectual property protection on drugs that are currently bringing tens of billions of dollars in sales and that subsidise expensive R&D efforts.

The future of healthcare in Europe

Report Summary

Across Europe, healthcare is barely managing to cover its costs. Not only are the methods for raising funds to cover its costs inadequate, but, of even greater concern, the costs themselves are set to soar. According to World Bank figures, public expenditure on healthcare in the EU could jump from 8% of GDP in 2000 to 14% in 2030 and continue to grow beyond that date. The overriding concern of Europe’s healthcare sector is to find ways to balance budgets and restrain spending. Unless that is done, the funds to pay for healthcare will soon fall short of demand.

Enjoy in-depth insights and expert analysis - subscribe to our Perspectives newsletter, delivered every week